• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Accessible at-home COVID-19 tests are designed with visually impaired, blind individuals in mind

Article

These new testing kits permit more equitable access to coronavirus testing.

A newly designed at-home COVID-19 test kit creates accessibility for individuals with visual impairments or blindness. These free testing kits are available through the US government.

These especially designed kits satisfy a need in which blind and visually impaired population cannot use standard rapid COVID-19 test kits on their own, and are designed with this patient population in mind, according to Ashish Jha, MD, MPH, the White House Response Coordinator.

The Administration for Community Living explained that 12 test kits are provided in each order; Medicare will provide up to 8 more tests each month. The recipients of the test kits must have a Bluetooth-enabled smartphone; a free app can be downloaded that provides audible instructions and the test results.

Individuals can contact the Disability Information and Access Line for help.

Patients are invited to call 1-800-232-0233 or order the tests online through the US Postal Service and COVIDTest.gov.

Jha commented that the newly designed test kit “ensures that everyone has equitable access to COVID-19 testing and all other critical…mitigation strategies is of the utmost importance.”

Reference
1. Suran M. Free COVID-19 tests for people with visual impairment. JAMA. 2022;328:699. doi:10.1001/jama.2022.14205
Related Videos
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
Edmund Tsui, MD, details what insights swept-source anterior segment OCT images may give to determining eye inflammation
Michael Chaglasian, OD, details success of new OCT device at the ARVO 2024 meeting
Emily Chew, MD, outlines her lecture that landed her the Proctor Award at ARVO 2024
Deborah Ferrington details a session on mitochondrial maintenance and retinal health in patients with AMD at ARVO 2024
Dr. John Sheppard discusses results from trials testing the efficacy of eye drops to treat dry eye disease
Kelsey Roelofs, MD, details the best methods to identify thyroid eye disease at CIME 2024
David A. Berntsen, OD, PhD, FAAO, outlines his presentation on the BLINK 2 study presented at the 2024 ARVO meeting
© 2024 MJH Life Sciences

All rights reserved.